Author | Paulo Marcelo Hoff, MD, PhD | OncLive

Author | Paulo Marcelo Hoff, MD, PhD

Articles

Dr. Hoff on Delivering Chemotherapy Until Progression Versus Complete Stop in mCRC

July 22, 2014

Video

Paulo Marcelo Hoff, MD, PhD, FACP, University of São Paulo, Brazil, discusses a meta-analysis of randomized trials that examined the effect of chemotherapy delivered until progression versus complete stop on the overall survival of patients with metastatic colorectal cancer (mCRC).

x